Segment Information

6 Months Ended

Jun. 30, 2012

Notes to Financial Statements [Abstract]

Segment Information

Segment Information

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments.  

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2012			2011			2012			2011
Net sales
Oral, Personal and Home Care
North America	$	758		$	744		$	1,513		$	1,462
Latin America	1,269			1,231			2,439			2,328
Europe/South Pacific	850			857			1,704			1,689
Greater Asia/Africa	859			816			1,738			1,629
Total Oral, Personal and Home Care	3,736			3,648			7,394			7,108
Pet Nutrition	531			537			1,073			1,071
Total Net sales	$	4,267		$	4,185		$	8,467		$	8,179
Operating profit
Oral, Personal and Home Care
North America	$	196		$	194		$	379		$	386
Latin America	367			360			711			686
Europe/South Pacific	179			170			362			355
Greater Asia/Africa	220			199			440			402
Total Oral, Personal and Home Care	962			923			1,892			1,829
Pet Nutrition	145			140			293			281
Corporate	(125		)	(95		)	(265		)	(227		)
Total Operating profit	$	982		$	968		$	1,920		$	1,883

For the six months ended June 30, 2012, Corporate Operating profit includes costs of $18 associated with the business realignment and other cost-saving initiatives and costs of $13 related to the sale of land in Mexico. For the three months ended June 30, 2012, Corporate Operating profit includes costs of $13 associated with the business realignment and other cost-saving initiatives and costs of $6 related to the sale of land in Mexico. The business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the sale of land in Mexico, refer to Note 4.